These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Therapy recommendations for the use of intravenously applicable immunoglobulins]. Marschner JP; Rietbrock N Med Klin (Munich); 1996 Mar; 91(3):141-7. PubMed ID: 8628200 [No Abstract] [Full Text] [Related]
7. Intravenous immunoglobulin therapy: the process, the product, the patient, and the pocketbook. Introduction. Harvey RD Pharmacotherapy; 2005 Nov; 25(11 Pt 2):71S-72S. PubMed ID: 16229676 [No Abstract] [Full Text] [Related]
8. [Intravenous immunoglobulins in dermatology]. Nydegger U; Hunziker T Ann Dermatol Venereol; 2002; 129(8-9):1078-81. PubMed ID: 12442118 [No Abstract] [Full Text] [Related]
11. Immunoglobulins and their use in children. Łaguna P; Gołębiowska-Staroszczyk S; Trzaska M; Grabarczyk M; Matysiak M Adv Clin Exp Med; 2015; 24(1):153-9. PubMed ID: 25923100 [TBL] [Abstract][Full Text] [Related]
13. Severe immunodeficiency associated with acute lymphoblastic leukemia and its treatment. Raje N; Snyder BL; Hill DA; Streicher JL; Sullivan KE Ann Allergy Asthma Immunol; 2018 May; 120(5):537-538.e1. PubMed ID: 29563054 [No Abstract] [Full Text] [Related]
14. Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies. Sibéril S; Elluru S; Negi VS; Ephrem A; Misra N; Delignat S; Bayary J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV Transfus Apher Sci; 2007 Aug; 37(1):103-7. PubMed ID: 17765663 [TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin (IVIg) for refractory and difficult-to-treat infections. Ferrara G; Zumla A; Maeurer M Am J Med; 2012 Oct; 125(10):1036.e1-8. PubMed ID: 22608788 [TBL] [Abstract][Full Text] [Related]
16. Tolerability and safety of the intravenous immunoglobulin Octagam: a 10-year prospective observational study. Debes A; Bauer M; Kremer S Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):1038-47. PubMed ID: 17636556 [TBL] [Abstract][Full Text] [Related]
17. [Use of IVIG in secondary immunodeficiencies]. Zeman K; Lewandowicz-Uszyńska A Postepy Hig Med Dosw; 2002; 56 Suppl():91-102. PubMed ID: 12661419 [TBL] [Abstract][Full Text] [Related]
18. The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis. Bode SF; Ammann S; Al-Herz W; Bataneant M; Dvorak CC; Gehring S; Gennery A; Gilmour KC; Gonzalez-Granado LI; Groß-Wieltsch U; Ifversen M; Lingman-Framme J; Matthes-Martin S; Mesters R; Meyts I; van Montfrans JM; Pachlopnik Schmid J; Pai SY; Soler-Palacin P; Schuermann U; Schuster V; Seidel MG; Speckmann C; Stepensky P; Sykora KW; Tesi B; Vraetz T; Waruiru C; Bryceson YT; Moshous D; Lehmberg K; Jordan MB; Ehl S; Haematologica; 2015 Jul; 100(7):978-88. PubMed ID: 26022711 [TBL] [Abstract][Full Text] [Related]